Avantor

Avantor, Inc. is a global biotechnology, chemicals, and life sciences company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, Avantor specializes in providing mission-critical products and services that support various sectors, including biotechnology, pharmaceuticals, and medical device manufacturing. Avantor supplies a broad range of products, from high-purity chemicals to lab supplies and single-use systems for biopharmaceutical production. It partners with clients in research, production, and delivery of critical therapies, including COVID-19 vaccines, gene therapies, and other advanced medical solutions.

Avantor operates within the biotechnology, chemicals, and life sciences industries. The company provides essential products and services to sectors including pharmaceuticals, medical devices, research laboratories, and biopharmaceutical manufacturing, contributing to advancements in healthcare, diagnostics, and scientific research.

Michael Stubblefield is the President and Chief Executive Officer of Avantor, a role he has held since May 2014. With a background in chemical engineering and extensive leadership experience in the chemicals and life sciences sectors, Mr. Stubblefield has overseen Avantor's significant growth, including strategic acquisitions and expansions in innovation and research capabilities.

R. Brent Jones serves as Avantor's Executive Vice President and Chief Financial Officer. In his role, he manages key financial functions, including financial planning, investor relations, treasury, and internal audit. With a diverse background in finance and operations from previous roles in global companies, Mr. Jones brings extensive expertise to support Avantor's growth and financial strategy.

Avantor uses technologies like SAP Quality Management, Microsoft OneNote, Dassault Systèmes, Dassault SolidWorks, Avention, SAP Supply Chain Management, Amazon AWS, Mac OS, and more.